REG - Eco Animal Health Gp - Share Awards to Executive Directors
29/08/2025 07:00
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250829:nRSc1368Xa&default-theme=true
RNS Number : 1368X Eco Animal Health Group PLC 29 August 2025
29 August 2025
ECO Animal Health Group plc
("ECO" or the "Company")
Share Awards to Executive Directors
ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health
company with a portfolio of marketed veterinary products and a maturing
proprietary R&D pipeline, announce that on 28 August 2025, nominal cost
conditional share options were granted under the Company's Long Term Incentive
Plan ("LTIP") over 374,318 ordinary shares in the Company (representing
approximately 0.55 percent of the Company's issued share capital) to the
Executive Directors listed below.
Name Position Number of Share Awards
David Hallas Chief Executive Officer 215,106
Chris Wilks Chief Financial Officer 159,212
These awards under the LTIP are subject to performance conditions being met
which have been set by the Company's Remuneration Committee and relate to
Total Shareholder Return ("TSR") and Research and Development ("R&D")
targets. Subject to the performance conditions being met, awards will vest
after the end of a three-year vesting period. Further details on the LTIP can
be found in the Company's 2025 Annual Report which was published on 28 August
2025.
In addition, on 28 August 2025 nominal cost share options were granted under
the Company's Deferred Bonus Plan ("DBS") over 60,295 ordinary shares in the
Company (representing approximately 0.09 percent of the Company's issued share
capital) to the two Executive Directors listed below. These awards relate to
the deferral of 33% of the annual bonus for Executive Directors earned in
respect of the Company's financial year ended 31 March 2025.
Name Position Number of Deferred Share Options
David Hallas Chief Executive Officer 35,472
Chris Wilks Chief Financial Officer 24,823
As indicated in the Circular to shareholders dated 4 February 2021, the DBS
has been established to allow the Remuneration Committee to require a
significant part of the annual bonuses paid to Executive Directors to be
deferred in exchange for an award of nominal cost options which vest after 3
years and are subject to malice and clawback provisions.
-Ends-
For further information please contact:
ECO Animal Health Group plc 020 8447 8899
David Hallas (CEO)
Christopher Wilks (CFO)
Singer Capital Markets (Nominated Adviser & Joint Broker) 020 7496 3000
Phil Davies
Sam Butcher
Investec (Joint Broker) 020 7597 5970
Gary Clarence
Lydia Zychowska
Equity Development 020 7065 2692
Hannah Crowe
Matt Evans
ICR Healthcare (Financial PR) 020 3709 5700
Mary-Jane Elliott ecoanimalhealth@icrhealthcare.com
Jessica Hodgson
About ECO Animal Health
ECO Animal Health is a world leader in animal health, developing and marketing
branded veterinary pharmaceuticals globally, with expertise in antibiotics and
vaccines for pigs and poultry. We have a maturing proprietary R&D
pipeline.
Headquartered in the UK, with global offices including R&D and
manufacturing, we have marketing authorisations in over 70 countries and
employ over 200 people worldwide.
Our lead product, Aivlosin® is a proprietary, patented medication which is
effective against both respiratory and intestinal diseases in pigs and
poultry.
Click here for more information: https://ecoanimalhealth.com
(https://ecoanimalhealth.com)
PDMR Notification - ECO LTIP Nominal Cost Conditional Share Awards
1. Details of the person discharging managerial responsibilities / person closely
associated
a. Name David Hallas
2. Reason for the notification
a. Position/status Chief Executive Officer
b. Initial notification Initial notification
/Amendment
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a. Name Eco Animal Health Group Plc
b. LEI 2138009XN9DJ3YP70B55
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a. Description of the Options over ordinary shares of 5p each.
Financial instrument, type of instrument
Identification code GB0032036807
b. Nature of the transaction 1. Award of nominal cost conditional share awards under the Company's
LTIP ("LTIP")
2. Nominal cost share awards under the Company's Deferred Bonus Plan
("DBS").
c. Price(s) and volume(s)
Price(s) Volume(s)
1. LTIP 5p 215,106
2. DBS 5p 35,472
d. Aggregated information
Aggregated volume
Price n/a
e. Date of the transaction 28 August 2025
f. Place of the transaction Off Market
d.
Aggregated information
Aggregated volume
Price
n/a
e.
Date of the transaction
28 August 2025
f.
Place of the transaction
Off Market
1. Details of the person discharging managerial responsibilities / person closely
associated
a. Name Chris Wilks
2. Reason for the notification
a. Position/status Chief Financial Officer
b. Initial notification Initial notification
/Amendment
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a. Name Eco Animal Health Group Plc
b. LEI 2138009XN9DJ3YP70B55
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a. Description of the Options over ordinary shares of 5p each.
Financial instrument, type of instrument
Identification code GB0032036807
b. Nature of the transaction 1. Award of nominal cost conditional share awards under the Company's
LTIP ("LTIP")
2. Nominal cost share awards under the Company's Deferred Bonus Plan
("DBS").
c. Price(s) and volume(s)
Price(s) Volume(s)
1. LTIP 5p 159,212
2. DBS 5p 24,823
d. Aggregated information
Aggregated volume
Price n/a
e. Date of the transaction 28 August 2025
f. Place of the transaction Off Market
d.
Aggregated information
Aggregated volume
Price
n/a
e.
Date of the transaction
28 August 2025
f.
Place of the transaction
Off Market
( )
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHBVLLLEVLLBBLRecent news on ECO Animal Health
See all newsREG - Eco Animal Health Gp - Appointment of Joint Broker
AnnouncementREG - Eco Animal Health Gp - Share Awards to Executive Directors
AnnouncementREG - Eco Animal Health Gp - Posting of Annual Report and Notice of AGM
AnnouncementREG - Eco Animal Health Gp - Result of General Meeting
AnnouncementREG - Eco Animal Health Gp - Block Listing Return
Announcement